| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.7B | $0.5B | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $1.49 | $2.01 | $2.21 | $2.32 | $2.23 | $1.84 | $0.52 | $0.52 |
| EPS (Diluted) | $1.47 | $1.98 | $2.18 | $2.29 | $2.20 | $1.83 | $0.52 | $0.51 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.1B | $12.0B | $12.3B | $12.3B | $12.9B | $10.5B | $9.7B | $7.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.3B | $0.7B | $0.7B | $0.2B | — | — | — | — |
| Total Liabilities | $15.6B | $10.7B | $11.0B | $11.2B | $11.5B | $9.3B | $8.5B | $6.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $2.5B | $1.4B | $1.3B | $1.1B | $1.3B | $1.3B | $1.2B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.2B |
| Investing Cash Flow | $1.1B | $0.7B | $0.6B | $-0.3B | $-0.8B | $-0.7B | $0.1B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-1.7B | $-0.9B | $-0.2B | $-0.5B | $0.8B | $0.7B | $0.1B | $-0.3B |